Discovery of a novel TFEB activator targeting lysosomal dysfunction in amyotrophic lateral sclerosis using artificial intelligence-based virtual screening

Ang Li, Xianglu Xiao, Dajiang Qin, Huanxing Su

Open source

DOI
10.1080/15548627.2026.2659295
Published
2026-04-20
Container
Autophagy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/15548627.2026.2659295,
  title = {Discovery of a novel TFEB activator targeting lysosomal dysfunction in amyotrophic lateral sclerosis using artificial intelligence-based virtual screening},
  author = {Ang Li and Xianglu Xiao and Dajiang Qin and Huanxing Su},
  year = {2026},
  journal = {Autophagy},
  doi = {10.1080/15548627.2026.2659295},
  url = {https://doi.org/10.1080/15548627.2026.2659295}
}

RIS

TY  - JOUR
TI  - Discovery of a novel TFEB activator targeting lysosomal dysfunction in amyotrophic lateral sclerosis using artificial intelligence-based virtual screening
AU  - Ang Li
AU  - Xianglu Xiao
AU  - Dajiang Qin
AU  - Huanxing Su
PY  - 2026
JO  - Autophagy
DO  - 10.1080/15548627.2026.2659295
UR  - https://doi.org/10.1080/15548627.2026.2659295
ER  - 

APA

Li, A., Xiao, X., Qin, D., & Su, H. (2026). Discovery of a novel TFEB activator targeting lysosomal dysfunction in amyotrophic lateral sclerosis using artificial intelligence-based virtual screening. Autophagy. https://doi.org/10.1080/15548627.2026.2659295

Source records